| Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study M Mohty, E Terpos, MV Mateos, M Cavo, S Lejniece, M Beksac, ... Clinical Lymphoma Myeloma and Leukemia 18 (10), e401-e419, 2018 | 77 | 2018 |
| Chronic lymphocytic leukemia with two cellular populations: a biphenotypic or biclonal disease J Gonzalez-Campos, E Rios-Herranz, JMD Blas-Orlando, A Martin-Noya, ... Annals of hematology 74, 243-246, 1997 | 32 | 1997 |
| Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from … C Jiménez-Cortegana, N Palazón-Carrión, AM Garcia-Sancho, ... Journal for immunotherapy of cancer 9 (6), 2021 | 28 | 2021 |
| A case-control analysis of the impact of venous thromboembolic disease on quality of life of patients with cancer: Quality of life in cancer (QCA) study L Marin-Barrera, AJ Muñoz-Martin, E Rios-Herranz, I Garcia-Escobar, ... Cancers 12 (1), 75, 2019 | 26 | 2019 |
| Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after nivolumab therapy for relapse/refractory Hodgkin lymphoma: real-life … C Martínez, C Carpio, I Heras, E Ríos-Herranz, J Buch, A Gutierrez, ... Biology of Blood and Marrow Transplantation 26 (8), 1534-1542, 2020 | 18 | 2020 |
| Guía de consenso nacionales para el estudio y tratamiento de los pacientes con leucemia linfocítica crónica JAG Marco, PG Castellano, JL Jiménez, ER Herranz, JLS Moral, ... Medicina Clínica 141 (4), 175. e1-175. e8, 2013 | 16 | 2013 |
| Aplastic anaemia and cyanamide E Rios-Herranz, V Carrasco-Baraja, D Lopez-Lacomba, JL Diez-Martin European journal of haematology 48 (3), 179, 1992 | 15 | 1992 |
| Intermediate doses of cytarabine plus granulocyte–colony‐stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with … C Calderón‐Cabrera, M Carmona Gonzalez, J Martín, E Rios Herranz, ... Transfusion 55 (4), 875-879, 2015 | 14 | 2015 |
| Multiple myeloma with numerous intranuclear Russell bodies A Martín-Noya, E Ríos-Herranz, E Rafel-Ribas Haematologica 84 (2), 179-180, 1999 | 8 | 1999 |
| Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-cell lymphoma: final results of the R2-GDP-GOTEL trial and immune biomarker subanalysis N Palazón-Carrión, A Martín García-Sancho, E Nogales-Fernández, ... Clinical Cancer Research 28 (17), 3658-3668, 2022 | 7 | 2022 |
| Case-control analysis of the impact of anemia on quality of life in patients with cancer: a Qca study analysis M Barca-Hernando, AJ Muñoz-Martin, E Rios-Herranz, I Garcia-Escobar, ... Cancers 13 (11), 2517, 2021 | 7 | 2021 |
| Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). Potential survival benefit for patients receiving allogeneic hematopoietic stem cell transplantation after … C Martínez, C Carpio, I Heras, E Ríos-Herranz, J Buch, A Gutierrez, ... Biol Blood Marrow Transplant 26 (8), 1534-1542, 2020 | 6 | 2020 |
| Fludarabine, cyclophosphamide and rituximab as first‐line treatment in patients with newly diagnosed follicular lymphoma F De la Cruz Vicente, E Carrillo‐Cruz, MS Rodriguez, A Marín Niebla, ... European Journal of Haematology 93 (6), 469-475, 2014 | 6 | 2014 |
| National guidelines for the management of patients with chronic lymphocytic leukemia. Sociedad Espan˜ ola de Hematologı´ ay Hemoterapia and Grupo Espan˜ ol de Leucemia Linfocı … GM JA, SM JL, TC MJ Medicina Clinica 141 (4), 175. e1-8, 2013 | 5 | 2013 |
| Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/Sezary syndrome. C Calderon Cabrera, F de la Cruz Vicente, A Marín‐Niebla, ... British journal of haematology 162 (1), 2013 | 4 | 2013 |
| Lenalidomide plus R-GDP (R2-GDP) in relapsed/refractory diffuse large B-cell lymphoma: Final results of the R2-GDP-GOTEL trial. L de la Cruz Merino, A Martin, E Nogales Fernandez, ... Journal of Clinical Oncology 38 (15_suppl), 8019-8019, 2020 | 3* | 2020 |
| Preliminary results of ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC7 trials from the Spanish … P Abrisqueta, E Gonzalez-Barca, CM Ferra, ER Herranz, M Fernandez, ... Blood 134, 4296, 2019 | 3 | 2019 |
| Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma C Guerrero, N Puig, MT Cedena, MJ Calasanz, NC Gutierrez, ... Blood 143 (7), 597-603, 2024 | 2 | 2024 |
| Rituximab, either as single agent or in combination, is superior to other treatments in terms of response rate and progression-free survival (PFS) in patients with splenic … A Marin-Niebla, M Else, F De la Cruz, P Batty, E Rios-Herranz, ... Blood 118 (21), 4986, 2011 | 2 | 2011 |
| Hodgkin's disease with epitrochlear onset JG FJ Anales de medicina interna (Madrid, Spain: 1984) 18 (10), 554-554, 2001 | 2 | 2001 |
